ArticleClinical rheumatology2026
Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics.
Richard H WoodsPubMed ↗Publisher ↗
No numbers read from the abstract.